digital health vendors glp-1 medication-assisted weight loss programs The Impact of Agonists on the MedTech Sector: Articulating a continued value proposition for devices Payer strategies for GLP-1 medications

Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

GlutaONE Antioxidant Supplement: Each serving of L-Glutathione liposomal antioxidant formula provides 1500 mg of a trademarked proprietary blend GlutaONE enriched with glutathione and essential phospholipids

The ongoing research mainly focuses on finding extended applications of already existing GLP-1 analogs

This chronic state of severe oxidative stress damages cellular membranes through a destructive process known as lipid peroxidation, creating a highly toxic internal cellular environment

This plan will take into account your medical history, current health conditions, and personal goals

doi: 10.1677/JOE-09-0132